Matches in Wikidata for { <http://www.wikidata.org/entity/Q66388780> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66388780 description "clinical trial" @default.
- Q66388780 description "ensayu clínicu" @default.
- Q66388780 description "klinisch onderzoek" @default.
- Q66388780 description "клінічне випробування" @default.
- Q66388780 name "Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis" @default.
- Q66388780 name "Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis" @default.
- Q66388780 type Item @default.
- Q66388780 label "Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis" @default.
- Q66388780 label "Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis" @default.
- Q66388780 prefLabel "Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis" @default.
- Q66388780 prefLabel "Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis" @default.
- Q66388780 P1050 Q66388780-4188152F-33B4-48DE-8692-E06C3961C4EE @default.
- Q66388780 P1132 Q66388780-34759E4D-851F-4189-8E1B-7D777F533FD2 @default.
- Q66388780 P1476 Q66388780-05500FC2-79F4-4AFC-996C-A7E14B00A729 @default.
- Q66388780 P17 Q66388780-596D7B0A-FA15-4274-AD6A-FCDE4C6980F1 @default.
- Q66388780 P2899 Q66388780-157FF08A-2C96-44C9-8B01-02178EDFAD41 @default.
- Q66388780 P3098 Q66388780-898F4C7C-EA8E-4C95-8B0A-A3EEDB9A8789 @default.
- Q66388780 P31 Q66388780-5AA4BD02-ABA7-42EC-AC44-E92EBD734D72 @default.
- Q66388780 P4135 Q66388780-88E8993F-680F-4A3F-87E4-C3F18054127F @default.
- Q66388780 P580 Q66388780-F149F73A-18BA-4A01-9217-5AD767EDEF8B @default.
- Q66388780 P582 Q66388780-D184C7C2-58FF-4E66-B8FF-B8AC75AFD2CE @default.
- Q66388780 P6099 Q66388780-DCB11351-CDA8-4D89-BBEE-61EDC0BEB655 @default.
- Q66388780 P8363 Q66388780-D739BED9-3D61-4389-9906-D1A251946160 @default.
- Q66388780 P1050 Q179945 @default.
- Q66388780 P1132 "+20" @default.
- Q66388780 P1476 "Open-Label Maximal Use Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis" @default.
- Q66388780 P17 Q30 @default.
- Q66388780 P2899 "+18" @default.
- Q66388780 P3098 "NCT04042103" @default.
- Q66388780 P31 Q30612 @default.
- Q66388780 P4135 "+75" @default.
- Q66388780 P580 "2019-07-23T00:00:00Z" @default.
- Q66388780 P582 "2020-02-28T00:00:00Z" @default.
- Q66388780 P6099 Q42824440 @default.
- Q66388780 P8363 Q78089383 @default.